Delivery Method: Via Email Product: Drugs Issuing Office: Center for Drug Evaluation and Research | CDER United States WARNING LETTER August 9, 2023 RE: 663668 Dear […]

Delivery Method: United Parcel Service Product: DrugsFood & Beverages Recipient: Recipient Name Mr. Michael Tsai Recipient Title COO STPCA Inc. dba Sun Ten Laboratories 9250 Jeronimo […]

Product: Drugs Recipient: Recipient Name Pascal Soriot Recipient Title Executive Director and Chief Executive Officer AstraZeneca Pharmaceuticals LP 1800 Concord PikeWilmington, DE 19850United States Issuing Office: […]

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Diego Velázquez Recipient Title Manager Laavo Clean, S.A. de C.V. Elías Flores Sur. No. 300Apodaca Centro66600 […]

Delivery Method: Certified Mail Product: Drugs Recipient: Recipient Name Mr. Jose Gaido Recipient Title President and Chief Executive Officer Denison Pharmaceuticals, LLC 1 Powder Hill Rd.Lincoln, […]

For Immediate Release: August 11, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, […]

Safety AnnouncementAdditional Information for ConsumersAdditional Information for Health Care ProfessionalsData SummaryReferences Safety Announcement [9-13-2012] The U.S. Food and Drug Administration (FDA) is alerting the public that […]

Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [12-22-2010] The U.S. Food and Drug Administration (FDA) is informing the […]

Safety AnnouncementAdditional Information for Patients with CKDAdditional Information for Healthcare Professionals who treat Patients with CKDTable of Key TrialsReferences Safety Announcement [6-24-2011] The U.S. Food and […]